Portola Pharmaceuticals, Inc.

Links: Y! PTLA Analyst ratings NEJM Apex FDA Calendar PTLA Reuters Investment Profile Report June 16 2018

PTLA / Message Board

Written By On Topic Only -- All Messages

Hide Replies

Keyword
Subject

Between			and
Rec'd By

Authored By
Minimum Recs

MSG #	SUBJECT	TYPE	AUTHOR	SENTIMENT	RECS	DATE POSTED
6605	CTCL opportunity	GN	erniewerner		3	12/9/2019 7:59:28 AM

6604	Re: Cerdulatinib at ASH	GN	erniewerner		4	12/9/2019 7:29:38 AM

6603	Re: Cerdulatinib at ASH	GN	erniewerner		2	12/9/2019 6:02:59 AM

6602	Re: Cerdulatinib at ASH	GN	seanleecfa		0	12/9/2019 2:23:44 AM

6601	Re: Cerdulatinib at ASH	GN	vegasguy	Strong Buy	0	12/9/2019 12:16:42 AM

6600	Cerdulatinib at ASH	GN	erniewerner		5	12/8/2019 8:53:55 PM

6599	Re: Andexxa Highlighted as a First-Line Factor Xa Reversal Option by the American College of Emergency Physicians	GN	JoeFlow		2	11/29/2019 11:12:39 AM

6598	Andexxa Highlighted as a First-Line Factor Xa Reversal Option by the American College of Emergency Physicians	GN	toohearn		9	11/29/2019 9:17:23 AM

6597	One more thing!	GN	businessman168		0	11/28/2019 2:41:35 AM

6596	Re: This is one sick puppy	GN	businessman168		0	11/27/2019 6:10:23 PM


	About Us • Contact Us • Follow Us on Twitter • Members Directory • Help Center • Advertise Not a member yet? What are you waiting for? Create Account Want to contribute? Support InvestorVillage by donating © 2003-2019 Investorvillage.com. All rights reserved. User Agreement